Nutriband - NTRB Total Company Value-to-Revenue Ratio

Nutriband Inc (NTRB) - corporate logo

Nutriband Inc. leverages the unique developments of Aversa transdermal systems, establishing a robust scientific and technological foundation. The EV-to-revenue trend confirms market expectations, with the metric fixed at 35543.21. While streamlined pharmacy distribution chains support business efficiency, high uncertainty persists due to stringent FDA oversight and a current lack of sales.

Nutriband Inc. (NTRB) - EV/Sales Multiple from 11/23/2025 to 11/20/2026

Nutriband Inc - analytical breakdowns and key metrics (NTRB)

- cash and cash flow indicators:
Fundamental valuation:Nutriband Inc NTRB
Finished products of Nutriband

The Enterprise Value-to-Revenue multiple reflects the market capitalization of Nutriband Inc. (NTRB) adjusted for net debt, comparing the total value of the business to its sales volume. This indicator assesses the investment attractiveness of the company's transdermal technologies, demonstrating how much investors are willing to pay per unit of revenue from patch commercialization while excluding the impact of debt load on the final valuation.